Tango Therapeutics, Inc 10-Q for FY2022 Q3
Tango Therapeutics, Inc. (TNGX)
10-Q
2022-11-10
For: 2022-09-30
View Original
Added on
April 08, 2026
About this 10-Q
Tango Therapeutics, Inc filed this 10-Q on November 10, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $6.92M
- up 2.0% from $6.79M a year earlier
- Net loss
- $29.05M
- compared with a net loss of $19.59M a year earlier
- Diluted EPS
- -$0.33
- compared with -$0.28 a year earlier